Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 9310522.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To establish the prevalence of endocrinologic disorders in children with neurofibromatosis type 1 (NF1) and the relationship between these disorders and cerebral abnormalities on magnetic resonance imaging. A prospective follow-up study. Setting. A multidisciplinary neurofibromatosis clinic. A total of 122 children diagnosed with NF1 according to diagnostic criteria set by the National Institutes of Health. Central precocious puberty (CPP) was diagnosed in 3 children and growth hormone deficiency (GHD) in 3 children. Optic pathway gliomas were observed in 15 children; in 9 of the 15 cases, the optic chiasm was involved. Of the 3 children with CPP, only 1 showed a chiasma glioma on magnetic resonance imaging. In 1 case with GHD, an optic chiasm glioma was detected on neuroimaging. Two of the 9 children with an optic chiasm glioma presented with CPP or GHD. It has been suggested that CPP in children with NF1 is found exclusively in the presence of a chiasma glioma. We conclude that chiasma glioma may not be obligatory in children with NF1 and CPP or GHD. Moreover, we report a prevalence of GHD in children with NF1 of 2.5%, which has not been established earlier.
Medical subject headings
- Cranial Nerve Neoplasms
- Glioma
- Human Growth Hormone
- Neurofibromatosis 1
- Optic Nerve Diseases
- Puberty, Precocious